JAMJOOM PHARMA

Jamjoom Pharmaceuticals Factory Co.

4015StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.50B	1.32B	1.10B	0.92B	0.74B
Cost of Revenue	565.06M	500.31M	399.03M	325.19M	260.99M
Gross Profit	935.56M	818.17M	701.79M	591.49M	474.69M
SG&A	432.55M	385.36M	350.42M	314.00M	251.89M
R&D	38.69M	34.00M	33.39M	32.68M	37.00M
Operating Expenses	460.45M	430.35M	385.98M	349.03M	288.89M
Operating Income	475.12M	387.82M	315.80M	242.46M	185.80M
Interest Income	4.41M	6.94M	—	—	—
Interest Expense	-192.55K	-101.45K	-112.09K	-122.26K	—
Other Income/Expense	-1.17M	-7.30M	-3.02M	-6.54M	1.28M
Pretax Income	493.10M	382.65M	315.80M	186.31M	188.09M
Income Tax	29.30M	26.13M	23.40M	15.00M	17.39M
Net Income	463.80M	356.52M	292.40M	171.31M	170.70M
EBITDA	517.11M	424.44M	341.70M	266.57M	209.63M
EBIT	475.12M	387.82M	315.80M	242.46M	185.80M
EPS (Basic)	6.63	5.09	4.18	2.45	17.07
EPS (Diluted)	6.63	5.09	4.18	2.45	17.07
DPS	4.00	3.06	2.50	—	—
Margins & Efficiency
Gross Margin %	+62.3%	+62.1%	+63.8%	+64.5%	+64.5%
EBITDA Margin %	+34.5%	+32.2%	+31.0%	+29.1%	+28.5%
Net Margin %	+30.9%	+27.0%	+26.6%	+18.7%	+23.2%
Revenue & Income
Revenue	1.50B	1.32B	1.10B	0.92B	0.74B
Revenue Growth (YoY)	+13.8%	+19.8%	+20.1%	+24.6%	-8.6%
Interest & Investment Income	4.41M	6.94M	—	—	—
Earnings From Equity Investments	13.84M	18.57M	4.41M	-0.32M	-0.05M
Gain (Loss) on Sale of Assets	—	—	—	30.76K	88.94K
Gain (Loss) on Sale of Investments	-0.10M	-4.52M	0.04M	0.01M	-1.04M
Currency Exchange Gain (Loss)	1.19M	-18.75M	-1.33M	-47.95M	2.01M
Expenses & Provisions
Cost of Revenue	565.06M	500.31M	399.03M	325.19M	260.99M
Selling, General & Admin	432.55M	385.36M	350.42M	314.00M	251.89M
Research & Development	38.69M	34.00M	33.39M	32.68M	37.00M
Operating Expenses	460.45M	430.35M	385.98M	349.03M	288.89M
Other Operating Expenses	-13.22M	-0.39M	0.08M	—	—
Interest Expense	-192.55K	-101.45K	-112.09K	-122.26K	—
Other Non Operating Income (Expenses)	-1.17M	-7.30M	-3.02M	-6.54M	1.28M
Asset Writedown	—	—	—	-1.25M	—
Impairment of Goodwill	—	—	—	—	—
D&A For EBITDA	41.99M	36.62M	25.89M	24.12M	23.82M
Profitability & Returns
Gross Profit	935.56M	818.17M	701.79M	591.49M	474.69M
Gross Margin	+62.3%	+62.1%	+63.8%	+64.5%	+64.5%
EBIT	475.12M	387.82M	315.80M	242.46M	185.80M
EBIT Margin	+31.7%	+29.4%	+28.7%	+26.5%	+25.3%
EBITDA	517.11M	424.44M	341.70M	266.57M	209.63M
EBITDA Margin	+34.5%	+32.2%	+31.0%	+29.1%	+28.5%
EBT Excluding Unusual Items	493.20M	387.18M	315.76M	187.53M	189.04M
Pretax Income	493.10M	382.65M	315.80M	186.31M	188.09M
Operating Income	475.12M	387.82M	315.80M	242.46M	185.80M
Operating Margin	+31.7%	+29.4%	+28.7%	+26.5%	+25.3%
Profit Margin	+30.9%	+27.0%	+26.6%	+18.7%	+23.2%
Net Income	463.80M	356.52M	292.40M	171.31M	170.70M
Net Income to Common	463.80M	356.52M	292.40M	171.31M	170.70M
Net Income Growth	+30.1%	+21.9%	+70.7%	+0.4%	-17.5%
Earnings From Continuing Ops.	463.80M	356.52M	292.40M	171.31M	170.70M
Income Tax Expense	29.30M	26.13M	23.40M	15.00M	17.39M
Effective Tax Rate	+5.9%	+6.8%	+7.4%	+8.1%	+9.2%
Per Share & Capital
EPS (Basic)	6.63	5.09	4.18	2.45	17.07
EPS (Diluted)	6.63	5.09	4.18	2.45	17.07
EPS Growth	+30.1%	+21.9%	+70.7%	-85.7%	-17.5%
Dividend Per Share	4.00	3.06	2.50	—	—
Shares Change (YoY)	—	—	—	6	—
Shares Outstanding (Basic)	70.00M	70.00M	70.00M	70.00M	10.00M
Shares Outstanding (Diluted)	70.00M	70.00M	70.00M	70.00M	10.00M
Dividend Growth	+30.7%	+22.4%	—	—	—
Free Cash Flow	353.25M	206.47M	250.74M	143.20M	101.90M
Free Cash Flow Margin	+23.5%	+15.7%	+22.8%	+15.6%	+13.9%
Free Cash Flow Per Share	5.05	2.95	3.58	2.05	10.19
Payout Ratio	+52.2%	+60.9%	+23.9%	+86.8%	+66.4%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operating Summary
Revenue	1.50B	1.32B	1.10B	0.92B	0.74B
Cost of Revenue	565.06M	500.31M	399.03M	325.19M	260.99M
Gross Profit	935.56M	818.17M	701.79M	591.49M	474.69M
SG&A	432.55M	385.36M	350.42M	314.00M	251.89M
R&D	38.69M	34.00M	33.39M	32.68M	37.00M
Operating Expenses	460.45M	430.35M	385.98M	349.03M	288.89M
Operating Income	475.12M	387.82M	315.80M	242.46M	185.80M
Interest Income	4.41M	6.94M	—	—	—
Interest Expense	-192.55K	-101.45K	-112.09K	-122.26K	—
Other Income/Expense	-1.17M	-7.30M	-3.02M	-6.54M	1.28M
Pretax Income	493.10M	382.65M	315.80M	186.31M	188.09M
Income Tax	29.30M	26.13M	23.40M	15.00M	17.39M
Net Income	463.80M	356.52M	292.40M	171.31M	170.70M
EBITDA	517.11M	424.44M	341.70M	266.57M	209.63M
EBIT	475.12M	387.82M	315.80M	242.46M	185.80M
EPS (Basic)	6.63	5.09	4.18	2.45	17.07
EPS (Diluted)	6.63	5.09	4.18	2.45	17.07
DPS	4.00	3.06	2.50	—	—
Margins & Efficiency
Gross Margin %	+62.3%	+62.1%	+63.8%	+64.5%	+64.5%
EBITDA Margin %	+34.5%	+32.2%	+31.0%	+29.1%	+28.5%
Net Margin %	+30.9%	+27.0%	+26.6%	+18.7%	+23.2%
Revenue & Income
Revenue	1.50B	1.32B	1.10B	0.92B	0.74B
Revenue Growth (YoY)	+13.8%	+19.8%	+20.1%	+24.6%	-8.6%
Interest & Investment Income	4.41M	6.94M	—	—	—
Earnings From Equity Investments	13.84M	18.57M	4.41M	-0.32M	-0.05M
Gain (Loss) on Sale of Assets	—	—	—	30.76K	88.94K
Gain (Loss) on Sale of Investments	-0.10M	-4.52M	0.04M	0.01M	-1.04M
Currency Exchange Gain (Loss)	1.19M	-18.75M	-1.33M	-47.95M	2.01M
Expenses & Provisions
Cost of Revenue	565.06M	500.31M	399.03M	325.19M	260.99M
Selling, General & Admin	432.55M	385.36M	350.42M	314.00M	251.89M
Research & Development	38.69M	34.00M	33.39M	32.68M	37.00M
Operating Expenses	460.45M	430.35M	385.98M	349.03M	288.89M
Other Operating Expenses	-13.22M	-0.39M	0.08M	—	—
Interest Expense	-192.55K	-101.45K	-112.09K	-122.26K	—
Other Non Operating Income (Expenses)	-1.17M	-7.30M	-3.02M	-6.54M	1.28M
Asset Writedown	—	—	—	-1.25M	—
Impairment of Goodwill	—	—	—	—	—
D&A For EBITDA	41.99M	36.62M	25.89M	24.12M	23.82M
Profitability & Returns
Gross Profit	935.56M	818.17M	701.79M	591.49M	474.69M
Gross Margin	+62.3%	+62.1%	+63.8%	+64.5%	+64.5%
EBIT	475.12M	387.82M	315.80M	242.46M	185.80M
EBIT Margin	+31.7%	+29.4%	+28.7%	+26.5%	+25.3%
EBITDA	517.11M	424.44M	341.70M	266.57M	209.63M
EBITDA Margin	+34.5%	+32.2%	+31.0%	+29.1%	+28.5%
EBT Excluding Unusual Items	493.20M	387.18M	315.76M	187.53M	189.04M
Pretax Income	493.10M	382.65M	315.80M	186.31M	188.09M
Operating Income	475.12M	387.82M	315.80M	242.46M	185.80M
Operating Margin	+31.7%	+29.4%	+28.7%	+26.5%	+25.3%
Profit Margin	+30.9%	+27.0%	+26.6%	+18.7%	+23.2%
Net Income	463.80M	356.52M	292.40M	171.31M	170.70M
Net Income to Common	463.80M	356.52M	292.40M	171.31M	170.70M
Net Income Growth	+30.1%	+21.9%	+70.7%	+0.4%	-17.5%
Earnings From Continuing Ops.	463.80M	356.52M	292.40M	171.31M	170.70M
Income Tax Expense	29.30M	26.13M	23.40M	15.00M	17.39M
Effective Tax Rate	+5.9%	+6.8%	+7.4%	+8.1%	+9.2%
Per Share & Capital
EPS (Basic)	6.63	5.09	4.18	2.45	17.07
EPS (Diluted)	6.63	5.09	4.18	2.45	17.07
EPS Growth	+30.1%	+21.9%	+70.7%	-85.7%	-17.5%
Dividend Per Share	4.00	3.06	2.50	—	—
Shares Change (YoY)	—	—	—	6	—
Shares Outstanding (Basic)	70.00M	70.00M	70.00M	70.00M	10.00M
Shares Outstanding (Diluted)	70.00M	70.00M	70.00M	70.00M	10.00M
Dividend Growth	+30.7%	+22.4%	—	—	—
Free Cash Flow	353.25M	206.47M	250.74M	143.20M	101.90M
Free Cash Flow Margin	+23.5%	+15.7%	+22.8%	+15.6%	+13.9%
Free Cash Flow Per Share	5.05	2.95	3.58	2.05	10.19
Payout Ratio	+52.2%	+60.9%	+23.9%	+86.8%	+66.4%